Carmot Therapeutics logo

Carmot Therapeutics

A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation

4

Funding Rounds

$223.5m

Money raised

Overview

A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation

Funding

Funding series

Funding Series Analysis

The company Carmot Therapeutics has raised a total of $208.55m in funding over 4 rounds.

Key Insights:

  • Carmot Therapeutics Inc. Funding Round, August 2022: $160m
  • Carmot Therapeutics Series C round, September 2020: $47m
  • Carmot Therapeutics funding round, April 2010: $1.55m
  • Carmot Therapeutics Inc funding round, January 2018: $15m
Carmot Therapeutics logo
Carmot Therapeutics Inc. Funding Round, August 2022 $160m
Carmot Therapeutics logo
Carmot Therapeutics Series C round, September 2020 $47m
Carmot Therapeutics logo
Carmot Therapeutics funding round, April 2010 $1.55m
Carmot Therapeutics logo
Carmot Therapeutics Inc funding round, January 2018 $15m

Industries

Carmot Therapeutics is active in the following industries: